文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

肾小管上皮细胞外泌体CCL2介导白蛋白诱导的肾小管间质炎症

Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation.
PubMed 文献 · J Am Soc Nephrol · 2018-01-02

本研究探讨肾小管上皮细胞(TEC)来源外泌体mRNA在白蛋白尿相关肾小管间质炎症中的作用。急慢性肾损伤模型小鼠肾脏和尿液中含炎症因子mRNA(尤其CCL2)的外泌体增多,BSA刺激TEC可重现此现象;TEC外泌体将CCL2 mRNA直接转移至巨噬细胞增强炎症反应,而CCL2沉默或缺陷则减轻效应。IgA肾病患者尿外泌体CCL2 mRNA与蛋白尿及肾间质巨噬细胞浸润相关。

要点

  • 白蛋白尿通过TEC外泌体传递CCL2 mRNA至巨噬细胞促炎
  • 尿外泌体CCL2 mRNA或反映IgA肾病肾间质巨噬细胞浸润
  • 沉默TEC的CCL2可减轻外泌体诱导的肾脏炎症

核心结论

  • TEC释放携带CCL2 mRNA的外泌体并转移至巨噬细胞,是白蛋白诱导肾小管间质炎症的关键机制。

研究设计与样本

  • 研究采用急性和慢性肾损伤小鼠模型、体外BSA刺激的TEC、巨噬细胞共培养及尾静脉注射纯化外泌体实验,并纳入IgA肾病患者分析尿外泌体。

主要发现

  • 与对照小鼠相比,急性和慢性肾损伤模型肾脏和尿液中含炎症因子mRNA(尤其CCL2)的外泌体增多。
  • BSA刺激TEC可重现外泌体增多,且巨噬细胞对BSA处理TEC外泌体的内化增加。
  • 巨噬细胞内化BSA处理TEC外泌体后炎症反应和迁移增强,而TEC中CCL2沉默可阻止这些效应。
  • GFP-CCL2融合mRNA构建体显示CCL2 mRNA从TEC外泌体直接转移至巨噬细胞。
  • 尾静脉注射BSA处理TEC外泌体的小鼠出现肾小管损伤和肾脏炎症细胞浸润,而注射CCL2缺陷TEC外泌体则炎症较轻。

临床怎么用

  • 尿外泌体CCL2 mRNA有望作为评估IgA肾病肾间质巨噬细胞浸润的无创生物标志物。
  • 靶向TEC外泌体CCL2 mRNA转移可能成为减轻白蛋白尿相关肾小管间质炎症的新策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Albuminuria is a key instigator of tubulointerstitial inflammation associated with CKD, but the mechanism through which filtered albumin propagates renal injury remains unclear. In this study, we explored the role in this process of exosome mRNA released from tubular epithelial cells (TECs). Compared with control mice, acute and chronic kidney injury models had more exosomes containing inflammatory cytokine mRNA, particularly the chemokine CCL2, in kidneys and urine. In vitro stimulation of TECs with BSA recapitulated this finding. Notably, the internalization of purified TEC exosomes by cultured macrophages increased if TECs were exposed to BSA. Macrophage internalization of exosomes from BSA-treated TECs led to an enhanced inflammatory response and macrophage migration, but CCL2 silencing in TECs prevented these effects. Using a GFP-CCL2 fusion mRNA construct, we observed direct transfer of CCL2 mRNA from TEC exosomes to macrophages. Mice subjected to tail vein injection of purified BSA-treated TEC exosomes developed tubular injury with renal inflammatory cell infiltration. However, injection of exosomes from BSA-treated CCL2-deficient TECs induced less severe kidney inflammation. Finally, in patients with IgA nephropathy, the increase of proteinuria correlated with augmented urinary excretion of exosomes with exaggerated expression of CCL2 mRNA. Moreover, the level of CCL2 mRNA in urinary exosomes correlated closely with levels of renal interstitial macrophage infiltration in these patients. Our studies demonstrate that the increasing release of exosomes that transfer CCL2 mRNA from TECs to macrophages constitutes a critical mechanism of albumin-induced tubulointerstitial inflammation.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lv LL, Feng Y, Wen Y, et al. Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation. J Am Soc Nephrol. 2018. PMID: 29295871. doi:10.1681/ASN.2017050523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。